P-326 Chemoradiotherapy treatment in gastroesophageal junction tumors

Abstract

mutation and the degree of differentiation or node invasion (p¼0.46 and p¼0.24 respectively). Conclusion:The prognostic impact of RAS mutation was demonstrated in our patients. Treatment for metastatic cancers remains challenging in Tunisia despite recent advances. Thanks to the identification of RAS status, unjustified expenses of anti-EGFR targeted therapy could be avoided.Legal entity responsible for the study: The authors.